Intracranial Pressure Monitoring Market Growth Fueled by Technological Advancements
The global intracranial pressure (ICP) monitoring market reached USD 2 billion in 2025 and is projected to grow at 5.25% through 2034. Increased neurological conditions and technological progress are key market drivers.
The global market for intracranial pressure (ICP) monitoring devices reached a value of USD 2 billion in 2025. Projections indicate a sustained growth rate of 5.25% annually from 2026 to 2034, with the market expected to reach USD 3.2 billion by the end of the forecast period.
This market expansion is primarily driven by the rising incidence of neurological disorders, including traumatic brain injuries, intracerebral hemorrhages, and meningitis. Advancements in monitoring technologies, both invasive and non-invasive, are also contributing significantly to market growth.
Technological innovations, such as improved computational algorithms for analyzing ICP waveforms and identifying cerebral vasoreactivity dysfunction, are enhancing diagnostic capabilities. Furthermore, government initiatives aimed at improving patient care and safety, alongside the critical role ICP monitoring played during the COVID-19 pandemic, have underscored its importance.
Key market segments include monitors, probes, and catheters, with invasive and non-invasive technologies playing crucial roles. Hospitals and trauma centers represent the primary end-users. Major industry players include Medtronic Plc, Integra Lifesciences Corporation, and DePuy Synthes (Johnson & Johnson).